CN1017626B - 生产新的细胞生长调节因子的方法 - Google Patents
生产新的细胞生长调节因子的方法Info
- Publication number
- CN1017626B CN1017626B CN86108955A CN86108955A CN1017626B CN 1017626 B CN1017626 B CN 1017626B CN 86108955 A CN86108955 A CN 86108955A CN 86108955 A CN86108955 A CN 86108955A CN 1017626 B CN1017626 B CN 1017626B
- Authority
- CN
- China
- Prior art keywords
- cell
- oncostatin
- factor
- suppress
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81123585A | 1985-12-20 | 1985-12-20 | |
| US811,235 | 1985-12-20 | ||
| US93528386A | 1986-11-26 | 1986-11-26 | |
| US935,283 | 1986-11-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN86108955A CN86108955A (zh) | 1987-12-02 |
| CN1017626B true CN1017626B (zh) | 1992-07-29 |
Family
ID=27123452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN86108955A Expired CN1017626B (zh) | 1985-12-20 | 1986-12-19 | 生产新的细胞生长调节因子的方法 |
Country Status (29)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4645828A (en) * | 1984-03-23 | 1987-02-24 | Oncogen | Platelet related growth regulator |
| US5681930A (en) * | 1985-12-20 | 1997-10-28 | Bristol-Myers Squibb Company | Anti-oncostatin M monoclonal antibodies |
| NZ218634A (en) * | 1985-12-20 | 1991-06-25 | Oncogen | Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits |
| NZ226799A (en) * | 1987-11-06 | 1991-08-27 | Oncogen | Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor |
| ZA912137B (en) * | 1990-03-29 | 1992-11-25 | Oncogen | Monocional antibodies that inhibit growth of kaposi's sarcoma |
| NZ237533A (en) * | 1990-03-29 | 1992-12-23 | Bristol Myers Squibb Co | Monoclonal antibodies which bind to oncostatin m, cell lines producing them |
| WO1992002556A1 (en) * | 1990-08-02 | 1992-02-20 | Michael Valentine Agrez | Human colon cancer cell-derived fibroblast elongation factor |
| CZ195193A3 (en) * | 1992-09-25 | 1994-04-13 | Lilly Co Eli | Modified factor-4 of blood platelets, process of its preparation and pharmaceutical preparation in which it is comprised |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4132776A (en) * | 1978-02-15 | 1979-01-02 | University Patents, Inc. | Delivery of immunologically active components of transfer factor |
| US4645828A (en) * | 1984-03-23 | 1987-02-24 | Oncogen | Platelet related growth regulator |
| NZ218634A (en) * | 1985-12-20 | 1991-06-25 | Oncogen | Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits |
-
1986
- 1986-12-15 NZ NZ218634A patent/NZ218634A/en unknown
- 1986-12-16 GB GB8629997A patent/GB2185485B/en not_active Expired - Lifetime
- 1986-12-16 AU AU66608/86A patent/AU601168B2/en not_active Expired
- 1986-12-17 ES ES8603468A patent/ES2003180A6/es not_active Expired
- 1986-12-17 LU LU86718A patent/LU86718A1/fr unknown
- 1986-12-17 NL NL8603209A patent/NL8603209A/nl not_active Application Discontinuation
- 1986-12-17 FI FI865156A patent/FI91484C/fi not_active IP Right Cessation
- 1986-12-17 BE BE0/217546A patent/BE905957A/fr not_active IP Right Cessation
- 1986-12-18 IL IL81017A patent/IL81017A/xx not_active IP Right Cessation
- 1986-12-18 CA CA000525706A patent/CA1340296C/en not_active Expired - Lifetime
- 1986-12-18 DK DK198606153A patent/DK174094B1/da not_active IP Right Cessation
- 1986-12-18 SE SE8605459A patent/SE505059C2/sv not_active IP Right Cessation
- 1986-12-19 NO NO865178A patent/NO174556C/no not_active IP Right Cessation
- 1986-12-19 KR KR1019860010968A patent/KR920005920B1/ko not_active Expired
- 1986-12-19 FR FR868617895A patent/FR2597108B1/fr not_active Expired - Lifetime
- 1986-12-19 HU HU865359A patent/HU210694B/hu unknown
- 1986-12-19 PT PT83986A patent/PT83986B/pt unknown
- 1986-12-19 IE IE334586A patent/IE59415B1/en not_active IP Right Cessation
- 1986-12-19 DE DE19863643428 patent/DE3643428A1/de active Granted
- 1986-12-19 CN CN86108955A patent/CN1017626B/zh not_active Expired
- 1986-12-19 JP JP61301853A patent/JP2559035B2/ja not_active Expired - Lifetime
- 1986-12-19 DE DE3645095A patent/DE3645095C2/de not_active Expired - Lifetime
- 1986-12-19 OA OA59026A patent/OA08494A/xx unknown
- 1986-12-19 IT IT8622787A patent/IT1213428B/it active
- 1986-12-22 GR GR862936A patent/GR862936B/el unknown
- 1986-12-22 CH CH5119/86A patent/CH675727A5/de unknown
- 1986-12-22 AT AT0340686A patent/AT400444B/de not_active IP Right Cessation
-
1990
- 1990-12-05 AU AU67765/90A patent/AU639048B2/en not_active Ceased
-
1991
- 1991-07-25 SG SG608/91A patent/SG60891G/en unknown
- 1991-08-15 HK HK656/91A patent/HK65691A/xx not_active IP Right Cessation
-
1992
- 1992-04-03 CY CY1608A patent/CY1608A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3375949B2 (ja) | 細胞障害性リンパ球成熟因子に対する抗体 | |
| KR100393508B1 (ko) | 인간 인터루킨 4의 안타고니스트 또는 부분적 아고니스트로서의 신규hIL-4 변이단백질 | |
| Cameron et al. | Purification to homogeneity and amino acid sequence analysis of two anionic species of human interleukin 1. | |
| SE504554C2 (sv) | Ett nytt bifunktionellt tillväxtmodulerande glykoprotein | |
| EA003942B1 (ru) | Усеченный по амино-концу моноцитарный хемотаксический белок (mcp-2) и способы его использования | |
| EP0122936B1 (en) | Lymphocyte growth factor | |
| CN1017626B (zh) | 生产新的细胞生长调节因子的方法 | |
| US4722998A (en) | Method of producing lymphocyte growth factors | |
| Gipson et al. | Comparison of 10 nm filaments from three bovine tissues | |
| US4720482A (en) | Pharmaceutical compositions containing one or more lymphocyte growth factors | |
| CN118027168B (zh) | 基于真核表达的msl重组植物蛋白的制备方法及用途 | |
| WO1992017500A1 (en) | Novel megakaryocyte amplifying factor and production thereof | |
| JPS6259299A (ja) | 新規なｃｓｆおよびその取得方法 | |
| JP4462706B2 (ja) | マクロファージ遊走阻止因子を含有する造血幹細胞増殖剤 | |
| CN114891122A (zh) | 一种原代奶牛乳腺上皮细胞生物反应器合成的奶牛抗菌多肽及其应用 | |
| FI98373B (fi) | Uusi diagnostisesti käyttökelpoinen polypeptidi, onkostatiini M | |
| CN1377408A (zh) | Prv－1基因及其应用 | |
| JPH03145499A (ja) | ヒト単球成長因子 | |
| JPS60149600A (ja) | インタ−フエロン−γ及びその製造方法 | |
| CN1220997A (zh) | 重组人肿瘤坏死因子及制备方法 | |
| JPS6130526A (ja) | リンパ球増殖因子 | |
| Rosner et al. | 4774321 DP100 EGF and insulin-binding protein from drosophila cells | |
| CN1283693A (zh) | 具有造血刺激和免疫调节作用的细胞因子cklf－h1a及其变异体cklf－h1b | |
| JPS59219234A (ja) | 腫瘍細胞増殖抑制因子の製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C13 | Decision | ||
| GR02 | Examined patent application | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C15 | Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993) | ||
| OR01 | Other related matters | ||
| C17 | Cessation of patent right | ||
| CX01 | Expiry of patent term |